Oramed Pharmaceuticals (Israel) Price Prediction and Hype Density Breakdown

ORMP -- Israel Stock  

null 1,732  108.00  5.87%

We analyze noise-free headlines and recent hype associated with Oramed Pharmaceuticals which may create opportunities for some arbitrage if properly timed. With Oramed Pharmaceuticals hype-based prediction module you can estimate the value of Oramed Pharmaceuticals from the prospective of Oramed Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Oramed Pharmaceuticals over a specific investment horizon. Additionally take a look at Your Equity Center.
Horizon     30 Days    Login   to change

Oramed Pharmaceuticals After-Hype Price Density Analysis

 Next price density 
 
Expected price to next headline

Oramed Pharmaceuticals Estimiated After-Hype Price Volatility

October 21, 2018
1,732
Current Value
0.00
After-hype Price
Target Odds
  
0.00
Upside
Oramed Pharmaceuticals is Unknown risk asset. Analysis and calculation of next after-hype price of Oramed Pharmaceuticals is based on 1 month time horizon.

Oramed Pharmaceuticals Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 1.05% 1.82% 0.00%  38.41% 0 Events / Month4 Events / MonthUncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1,7320.000.00%
0.00% 

Oramed Pharmaceuticals Hype Timeline

Oramed Pharmaceuticals is now traded for 1,732on Tel Aviv Stock Exchange of Israel. This company stock is not elastic to its hype. The average elasticity to hype of competition is 38.41. Oramed Pharmaceuticals is anticipated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 0.0%. The immediate return on the next news is anticipated to be very small where as daily expected return is now at 1.05%. The volatility of relative hype elasticity to Oramed Pharmaceuticals is about 4.98%%. The volatility of related hype on Oramed Pharmaceuticals is about 4.98% with expected price after next announcement by competition of 1770.41. The company recorded loss per share of 0.88. Oramed Pharmaceuticals had not issued any dividends in recent years. Assuming 30 trading days horizon, the next anticipated press release will be uncertain.
Additionally take a look at Your Equity Center.

Oramed Pharmaceuticals Related Hype Analysis

Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
Bezeq The Israel Telecommunication Corporation Limited(5.00) 1 per month 1.52  0.09  2.39 (2.40)  11.29 
Oil Refineries Ltd(3.20) 4 per month 0.00 (0.15)  0.98 (1.76)  6.31 
Perrigo Company plc 330.00 2 per month 0.00  0.0313  4.18 (2.43)  10.37 
Bank Leumi le Israel B M 0.00 0 per month 0.87  0.25  1.09 (1.42)  2.90 
Israel Chemicals Ltd 18.00 1 per month 0.66  0.41  3.78 (1.84)  6.49 
NICE Ltd(500.00) 5 per month 0.00 (0.11)  2.34 (2.90)  7.15 
Azrieli Group Ltd 600.00 1 per month 0.00  0.0359  1.83 (1.88)  4.65 
Elbit Systems Ltd(130.00) 3 per month 0.00  0.026  3.18 (3.41)  8.84 
Mizrahi Tefahot Bank Ltd 52.00 1 per month 0.00  0.13  1.69 (1.50)  3.44 
Israel Discount Bank Limited 4.00 1 per month 0.00  0.1  2.44 (1.56)  6.86 

Latest Stories

Recently Published Macroaxis Stories

Investors are also interested in

Purchased over 300 shares
Active few hours ago
Purchased over 40 shares
Active few hours ago
Purchased over 100 shares
Active few hours ago
Purchased over 90 shares
Active few hours ago
Purchased over 20 shares
Active few hours ago
Additionally take a look at Your Equity Center. Please also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. drill down to check world indexes.
Search macroaxis.com